Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 173 entries
Sorted by: Best Match Show Resources per page
The recruitment and training of psychiatric residents for research.

Psychopharmacology bulletin

Rieder RO.
PMID: 3212164
Psychopharmacol Bull. 1988;24(2):288-90.

No abstract available.

Cite
Rieder RO. The recruitment and training of psychiatric residents for research. Psychopharmacol Bull. 1988;24(2):288-90
Rieder, R. O. (1988). The recruitment and training of psychiatric residents for research. Psychopharmacology bulletin, 24(2), 288-90.
Rieder, R O. "The recruitment and training of psychiatric residents for research." Psychopharmacology bulletin vol. 24,2 (1988): 288-90.
Rieder RO. The recruitment and training of psychiatric residents for research. Psychopharmacol Bull. 1988;24(2):288-90. PMID: 3212164.
Copy Download .nbib Format: NLM
Treatment outcome research for depression in mentally retarded children and youth: methodological issues.

Psychopharmacology bulletin

Matson JL.
PMID: 3809374
Psychopharmacol Bull. 1986;22(4):1081-5.

No abstract available.

Cite
Matson JL. Treatment outcome research for depression in mentally retarded children and youth: methodological issues. Psychopharmacol Bull. 1986;22(4):1081-5
Matson, J. L. (1986). Treatment outcome research for depression in mentally retarded children and youth: methodological issues. Psychopharmacology bulletin, 22(4), 1081-5.
Matson, J L. "Treatment outcome research for depression in mentally retarded children and youth: methodological issues." Psychopharmacology bulletin vol. 22,4 (1986): 1081-5.
Matson JL. Treatment outcome research for depression in mentally retarded children and youth: methodological issues. Psychopharmacol Bull. 1986;22(4):1081-5. PMID: 3809374.
Copy Download .nbib Format: NLM
Immune correlates of stress and depression.

Psychopharmacology bulletin

Evans DL, Leserman J, Pedersen CA, Golden RN, Lewis MH, Folds JA, Ozer H.
PMID: 2697005
Psychopharmacol Bull. 1989;25(3):319-24.

This paper reviews the evidence for alterations in immunity associated with depression and stressful events. The reviewed studies examine a variety of immune parameters (e.g., mitogen response, natural killer cell activity and number, T-cell, and T-cell subpopulations) in relation...

Cite
Evans DL, Leserman J, Pedersen CA, et al. Immune correlates of stress and depression. Psychopharmacol Bull. 1989;25(3):319-24
Evans, D. L., Leserman, J., Pedersen, C. A., Golden, R. N., Lewis, M. H., Folds, J. A., & Ozer, H. (1989). Immune correlates of stress and depression. Psychopharmacology bulletin, 25(3), 319-24.
Evans, D L, et al. "Immune correlates of stress and depression." Psychopharmacology bulletin vol. 25,3 (1989): 319-24.
Evans DL, Leserman J, Pedersen CA, Golden RN, Lewis MH, Folds JA, Ozer H. Immune correlates of stress and depression. Psychopharmacol Bull. 1989;25(3):319-24. PMID: 2697005.
Copy Download .nbib Format: NLM
How well can patients discriminate drug-related side effects from extraneous new symptoms?.

Psychopharmacology bulletin

Solovitz BL, Fisher S, Bryant SG, Kluge RM.
PMID: 3602319
Psychopharmacol Bull. 1987;23(1):189-92.

No abstract available.

Cite
Solovitz BL, Fisher S, Bryant SG, et al. How well can patients discriminate drug-related side effects from extraneous new symptoms?. Psychopharmacol Bull. 1987;23(1):189-92
Solovitz, B. L., Fisher, S., Bryant, S. G., & Kluge, R. M. (1987). How well can patients discriminate drug-related side effects from extraneous new symptoms?. Psychopharmacology bulletin, 23(1), 189-92.
Solovitz, B L, et al. "How well can patients discriminate drug-related side effects from extraneous new symptoms?." Psychopharmacology bulletin vol. 23,1 (1987): 189-92.
Solovitz BL, Fisher S, Bryant SG, Kluge RM. How well can patients discriminate drug-related side effects from extraneous new symptoms?. Psychopharmacol Bull. 1987;23(1):189-92. PMID: 3602319.
Copy Download .nbib Format: NLM
Neuroanatomical circuits in depression: implications for treatment mechanisms.

Psychopharmacology bulletin

Drevets WC, Raichle ME.
PMID: 1480730
Psychopharmacol Bull. 1992;28(3):261-74.

We previously investigated the functional neuroanatomy of familial pure depressive disease (FPDD) using positron emission tomography (PET) measurements of regional blood flow and obtained evidence that flow is increased in the left prefrontal cortex, amygdala, and medial thalamus and...

Cite
Drevets WC, Raichle ME. Neuroanatomical circuits in depression: implications for treatment mechanisms. Psychopharmacol Bull. 1992;28(3):261-74
Drevets, W. C., & Raichle, M. E. (1992). Neuroanatomical circuits in depression: implications for treatment mechanisms. Psychopharmacology bulletin, 28(3), 261-74.
Drevets, W C, and Raichle, M E. "Neuroanatomical circuits in depression: implications for treatment mechanisms." Psychopharmacology bulletin vol. 28,3 (1992): 261-74.
Drevets WC, Raichle ME. Neuroanatomical circuits in depression: implications for treatment mechanisms. Psychopharmacol Bull. 1992;28(3):261-74. PMID: 1480730.
Copy Download .nbib Format: NLM
Selecting an interim analysis procedure.

Psychopharmacology bulletin

Overall JE, Atlas RS.
PMID: 8290658
Psychopharmacol Bull. 1993;29(2):141-7.

Motivations for undertaking interim analyses differ, as do the methods proposed by different authors. This article evaluates five interim analysis procedures with regard to different requirements. The five procedures differ with respect to concern for the presence or absence...

Cite
Overall JE, Atlas RS. Selecting an interim analysis procedure. Psychopharmacol Bull. 1993;29(2):141-7
Overall, J. E., & Atlas, R. S. (1993). Selecting an interim analysis procedure. Psychopharmacology bulletin, 29(2), 141-7.
Overall, J E, and Atlas, R S. "Selecting an interim analysis procedure." Psychopharmacology bulletin vol. 29,2 (1993): 141-7.
Overall JE, Atlas RS. Selecting an interim analysis procedure. Psychopharmacol Bull. 1993;29(2):141-7. PMID: 8290658.
Copy Download .nbib Format: NLM
Test of treatment in psychiatric practice.

Psychopharmacology bulletin

Mustafa FA.
PMID: 22506439
Psychopharmacol Bull. 2011;44(1):61-4.

Due to lack of laboratorial investigations in psychiatric practice, tests of treatment are often used to aid diagnosis. This article provides examples of test of treatment in psychiatric practice and outlines their limitations.

Cite
Mustafa FA. Test of treatment in psychiatric practice. Psychopharmacol Bull. 2011;44(1):61-4
Mustafa, F. A. (2011). Test of treatment in psychiatric practice. Psychopharmacology bulletin, 44(1), 61-4.
Mustafa, Feras Ali. "Test of treatment in psychiatric practice." Psychopharmacology bulletin vol. 44,1 (2011): 61-4.
Mustafa FA. Test of treatment in psychiatric practice. Psychopharmacol Bull. 2011;44(1):61-4. PMID: 22506439; PMCID: PMC5044557.
Copy Download .nbib Format: NLM
Evaluation of mental health and depression during pregnancy: position paper.

Psychopharmacology bulletin

Altshuler L, Cohen L, Hendrick V, Stowe Z.
PMID: 9803758
Psychopharmacol Bull. 1998;34(3):297-9.

Women in their reproductive years constitute the population at greatest risk for major depression. Consequently, many women will experience depression during the course of conception and pregnancy. Rates of major depression among pregnant women appear to be equivalent to...

Cite
Altshuler L, Cohen L, Hendrick V, et al. Evaluation of mental health and depression during pregnancy: position paper. Psychopharmacol Bull. 1998;34(3):297-9
Altshuler, L., Cohen, L., Hendrick, V., & Stowe, Z. (1998). Evaluation of mental health and depression during pregnancy: position paper. Psychopharmacology bulletin, 34(3), 297-9.
Altshuler, L, et al. "Evaluation of mental health and depression during pregnancy: position paper." Psychopharmacology bulletin vol. 34,3 (1998): 297-9.
Altshuler L, Cohen L, Hendrick V, Stowe Z. Evaluation of mental health and depression during pregnancy: position paper. Psychopharmacol Bull. 1998;34(3):297-9. PMID: 9803758.
Copy Download .nbib Format: NLM
Impact of Recent Methamphetamine Use on Vancomycin Clearance.

Psychopharmacology bulletin

Laguado SA, Vadiei N, Yenina K.
PMID: 32733109
Psychopharmacol Bull. 2020 Jul 23;50(3):23-35.

PURPOSE: To determine whether recent methamphetamine use increases vancomycin clearance.METHODS: This was a multi-center, retrospective, IRB-approved study at two tertiary care medical centers. Adult patients with a urine drug screen, ≥3 consecutive vancomycin doses, and an appropriately drawn vancomycin...

Cite
Laguado SA, Vadiei N, Yenina K. Impact of Recent Methamphetamine Use on Vancomycin Clearance. Psychopharmacol Bull. 2020;50(3):23-35
Laguado, S. A., Vadiei, N., & Yenina, K. (2020). Impact of Recent Methamphetamine Use on Vancomycin Clearance. Psychopharmacology bulletin, 50(3), 23-35.
Laguado, S Andrea, et al. "Impact of Recent Methamphetamine Use on Vancomycin Clearance." Psychopharmacology bulletin vol. 50,3 (2020): 23-35.
Laguado SA, Vadiei N, Yenina K. Impact of Recent Methamphetamine Use on Vancomycin Clearance. Psychopharmacol Bull. 2020 Jul 23;50(3):23-35. PMID: 32733109; PMCID: PMC7377544.
Copy Download .nbib Format: NLM
Naldemedine for the Use of Management of Opioid Induced Constipation.

Psychopharmacology bulletin

Urits I, Patel A, Kiernan HC, Clay CJ, Monteferrante N, Jung JW, Berger AA, Kassem H, Hasoon J, Kaye AD, Kaye AM, Viswanath O.
PMID: 32733114
Psychopharmacol Bull. 2020 Jul 23;50(3):97-118.

PURPOSE OF REVIEW: Opioid medications are a pillar of acute and chronic analgesia, though their use is often accompanied by side-effects, such as opioid-induced constipation. Unfortunately, tolerance rarely develops to this untoward side effect. This review presents the background,...

Cite
Urits I, Patel A, Kiernan HC, et al. Naldemedine for the Use of Management of Opioid Induced Constipation. Psychopharmacol Bull. 2020;50(3):97-118
Urits, I., Patel, A., Kiernan, H. C., Clay, C. J., Monteferrante, N., Jung, J. W., Berger, A. A., Kassem, H., Hasoon, J., Kaye, A. D., Kaye, A. M., & Viswanath, O. (2020). Naldemedine for the Use of Management of Opioid Induced Constipation. Psychopharmacology bulletin, 50(3), 97-118.
Urits, Ivan, et al. "Naldemedine for the Use of Management of Opioid Induced Constipation." Psychopharmacology bulletin vol. 50,3 (2020): 97-118.
Urits I, Patel A, Kiernan HC, Clay CJ, Monteferrante N, Jung JW, Berger AA, Kassem H, Hasoon J, Kaye AD, Kaye AM, Viswanath O. Naldemedine for the Use of Management of Opioid Induced Constipation. Psychopharmacol Bull. 2020 Jul 23;50(3):97-118. PMID: 32733114; PMCID: PMC7377540.
Copy Download .nbib Format: NLM
Use of Clozapine in the General Hospital.

Psychopharmacology bulletin

Mustafa FA.
PMID: 32733115
Psychopharmacol Bull. 2020 Jul 23;50(3):119-124.

Patients with treatment-resistant schizophrenia receiving clozapine therapy are at risk of potentially serious complications in the general hospital setting, due to the complex pharmacokinetic and pharmacodynamic profile of clozapine. We summarize common clinical challenges that face clinicians who care...

Cite
Mustafa FA. Use of Clozapine in the General Hospital. Psychopharmacol Bull. 2020;50(3):119-124
Mustafa, F. A. (2020). Use of Clozapine in the General Hospital. Psychopharmacology bulletin, 50(3), 119-124.
Mustafa, Feras Ali. "Use of Clozapine in the General Hospital." Psychopharmacology bulletin vol. 50,3 (2020): 119-124.
Mustafa FA. Use of Clozapine in the General Hospital. Psychopharmacol Bull. 2020 Jul 23;50(3):119-124. PMID: 32733115; PMCID: PMC7377545.
Copy Download .nbib Format: NLM
Intrathecal Morphine Delivery at Cisterna Magna to Control Refractory Cancer-Related Pain: A Prospective Cohort Study.

Psychopharmacology bulletin

Sun C, Wang YT, Dai YJ, Liu ZH, Yang J, Cheng ZQ, Dong DS, Wang CF, Zhao GL, Lu GJ, Song T, Jin Y, Sun LL, Kaye AD, Urits I, Viswanath O, Sun YH.
PMID: 33633417
Psychopharmacol Bull. 2020 Oct 15;50(4):48-66.

BACKGROUND: For patients suffering from primary or metastatic cancer above the middle thoracic vertebrae, refractory pain management still remains a great challenge. Theoretically, inserting a catheter tip into the cisterna magna may be a promising solution. However, at present,...

Cite
Sun C, Wang YT, Dai YJ, et al. Intrathecal Morphine Delivery at Cisterna Magna to Control Refractory Cancer-Related Pain: A Prospective Cohort Study. Psychopharmacol Bull. 2020;50(4):48-66
Sun, C., Wang, Y. T., Dai, Y. J., Liu, Z. H., Yang, J., Cheng, Z. Q., Dong, D. S., Wang, C. F., Zhao, G. L., Lu, G. J., Song, T., Jin, Y., Sun, L. L., Kaye, A. D., Urits, I., Viswanath, O., & Sun, Y. H. (2020). Intrathecal Morphine Delivery at Cisterna Magna to Control Refractory Cancer-Related Pain: A Prospective Cohort Study. Psychopharmacology bulletin, 50(4), 48-66.
Sun, Chang, et al. "Intrathecal Morphine Delivery at Cisterna Magna to Control Refractory Cancer-Related Pain: A Prospective Cohort Study." Psychopharmacology bulletin vol. 50,4 (2020): 48-66.
Sun C, Wang YT, Dai YJ, Liu ZH, Yang J, Cheng ZQ, Dong DS, Wang CF, Zhao GL, Lu GJ, Song T, Jin Y, Sun LL, Kaye AD, Urits I, Viswanath O, Sun YH. Intrathecal Morphine Delivery at Cisterna Magna to Control Refractory Cancer-Related Pain: A Prospective Cohort Study. Psychopharmacol Bull. 2020 Oct 15;50(4):48-66. PMID: 33633417; PMCID: PMC7901124.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 173 entries